← Open Payments lookup

CARMEN LANDAVERDE: Open Payments

NPI 1902093263 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$103,564 in 167 payments from 12 companies in 2025. Trend: 2023 $15,995 · 2024 $47,491 · 2025 $103,564

Speaker / faculty: $55,243Consulting: $19,060Travel & lodging: $11,889Speaker / faculty: $10,800Food & beverage: $6,573
CompanyPaymentsAmount
Madrigal Pharmaceuticals34$42,555
Intercept Pharmaceuticals, Inc.29$19,865
Gilead Sciences, Inc.27$14,085
Ipsen Biopharmaceuticals, Inc18$13,080
Mirum Pharmaceuticals, Inc.32$11,182
Boston Scientific Corporation8$2,295
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$201
HISTOSONICS, INC.1$140
Novo Nordisk Inc2$50
Eton Pharmaceuticals, Inc.1$45

Products named: REZDIFFRA, OCALIVA, IQIRVO, Livdelzi, Livmarli, TheraSphere Y90 Glass Microspheres 10 GBq, Epclusa, XIFAXAN.

Industry payments across TX — which companies pay providers there.